Comerica Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $935K | Sell |
16,108
-13
| -0.1% | -$797 | 0.08% | 211 |
|
|
2023
Q2 | $1.03M | Sell |
16,121
-1,943
| -11% | -$130K | 0.07% | 225 |
|
|
2023
Q1 | $1.25M | Buy |
18,064
+361
| +2% | +$25.5K | 0.09% | 198 |
|
|
2022
Q4 | $1.27M | Buy |
17,703
+1,504
| +9% | +$113K | 0.09% | 194 |
|
|
2022
Q3 | $1.15M | Sell |
16,199
-2,075
| -11% | -$151K | 0.09% | 191 |
|
|
2022
Q2 | $1.42M | Buy |
18,274
+1,645
| +10% | +$125K | 0.11% | 182 |
|
|
2022
Q1 | $1.22M | Buy |
16,629
+5,907
| +55% | +$397K | 0.08% | 199 |
|
|
2021
Q4 | $669K | Sell |
10,722
-15,128
| -59% | -$887K | 0.04% | 285 |
|
|
2021
Q3 | $1.54M | Buy |
25,850
+1,467
| +6% | +$96.6K | 0.11% | 172 |
|
|
2021
Q2 | $1.63M | Sell |
24,383
-1,109
| -4% | -$72.3K | 0.12% | 150 |
|
|
2021
Q1 | $1.62M | Sell |
25,492
-2,481
| -9% | -$154K | 0.12% | 154 |
|
|
2020
Q4 | $1.75M | Buy |
27,973
+24
| +0.1% | +$1.48K | 0.14% | 137 |
|
|
2020
Q3 | $1.69M | Buy |
27,949
+1,019
| +4% | +$61.3K | 0.15% | 128 |
|
|
2020
Q2 | $1.58M | Sell |
26,930
-12,429
| -32% | -$743K | 0.15% | 133 |
|
|
2020
Q1 | $2.19M | Buy |
39,359
+28,603
| +266% | +$1.75M | 0.25% | 101 |
|
|
2019
Q4 | $690K | Buy |
10,756
+2,866
| +36% | +$164K | 0.07% | 256 |
|
|
2019
Q3 | $400K | Buy |
7,890
+849
| +12% | +$39.9K | 0.04% | 307 |
|
|
2019
Q2 | $319K | Buy |
7,041
+699
| +11% | +$32.6K | 0.03% | 329 |
|
|
2019
Q1 | $303K | Buy |
6,342
+295
| +5% | +$14.7K | 0.03% | 338 |
|
|
2018
Q4 | $314K | Buy |
6,047
+409
| +7% | +$22K | 0.04% | 313 |
|
|
2018
Q3 | $350K | Buy |
5,638
+328
| +6% | +$19.5K | 0.04% | 323 |
|
|
2018
Q2 | $294K | Sell |
5,310
-120
| -2% | -$6.48K | 0.04% | 343 |
|
|
2018
Q1 | $343K | Buy |
5,430
+201
| +4% | +$12.9K | 0.04% | 308 |
|
|
2017
Q4 | $320K | Sell |
5,229
-130
| -2% | -$8.13K | 0.04% | 321 |
|
|
2017
Q3 | $342K | Sell |
5,359
-39
| -0.7% | -$2.28K | 0.05% | 305 |
|
|
2017
Q2 | $301K | Buy |
5,398
+228
| +4% | +$12.4K | 0.04% | 317 |
|
|
2017
Q1 | $281K | Sell |
5,170
-820
| -14% | -$45K | 0.04% | 324 |
|
|
2016
Q4 | $350K | Buy |
+5,990
| New | +$327K | 0.09% | 249 |
|
|
2016
Q3 | – | Sell |
-5,186
| Closed | -$381K | – | 351 |
|
|
2016
Q2 | $381K | Buy |
5,186
+174
| +3% | +$12.3K | 0.08% | 232 |
|
|
2016
Q1 | $320K | Buy |
+5,012
| New | +$316K | 0.08% | 246 |
|
Other funds holding BMY
Comerica Securities's BMY Position: Q3 2023 in Review
Comerica Securities reduced its Bristol-Myers Squibb (BMY) stake by 0.08% in Q3 2023, selling an estimated $797 and leaving 16,108 shares worth $935K. The position accounts for 0.08% of the portfolio, ranked #211.
Comerica Securities first reported a position in BMY in Q1 2016 and has held it in 30 quarters since. The position peaked at $2.19M in Q1 2020. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- Comerica Securities held 16,108 shares of Bristol-Myers Squibb worth $935K as of Q3 2023.
- Comerica Securities sold 13 Bristol-Myers Squibb shares in Q3 2023, an estimated $797.
- Bristol-Myers Squibb made up 0.08% of Comerica Securities's portfolio in Q3 2023, its #211 holding.
- Comerica Securities first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 30 quarters since.
- Comerica Securities's Bristol-Myers Squibb position peaked at $2.19M in Q1 2020.
- 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.